Orient EuroPharma Co., Ltd. (TPEX:4120)
Taiwan · Delayed Price · Currency is TWD 46.50
-0.40 (-0.85%)
Jul 30, 2026, 11:19 AM CST
Orient EuroPharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,747 | 1,950 | 1,435 | 1,736 | 1,801 | 1,959 |
Short-Term Investments | 106.91 | 135.9 | 174.26 | 159.52 | 70.8 | 80.8 |
Cash & Short-Term Investments | 1,854 | 2,086 | 1,609 | 1,896 | 1,872 | 2,040 |
Cash Growth | 30.24% | 29.59% | -15.10% | 1.27% | -8.25% | -12.19% |
Accounts Receivable | 794.24 | 817.68 | 847.2 | 783.01 | 730.48 | 580.03 |
Other Receivables | 57.66 | 26.72 | 21.44 | 26.94 | 27.66 | 33.53 |
Receivables | 851.9 | 844.41 | 868.64 | 809.94 | 758.15 | 613.55 |
Inventory | 1,089 | 1,122 | 1,065 | 1,147 | 1,304 | 1,082 |
Prepaid Expenses | 208.19 | 184 | 137.26 | 118.23 | 162.21 | 136.07 |
Other Current Assets | 32.49 | 62.39 | 295.84 | 257.28 | 88.62 | 53.63 |
Total Current Assets | 4,036 | 4,298 | 3,976 | 4,228 | 4,185 | 3,925 |
Property, Plant & Equipment | 3,861 | 3,857 | 3,851 | 3,986 | 4,019 | 4,181 |
Long-Term Investments | 2,263 | 2,607 | 2,296 | 1,064 | 533.57 | 416.83 |
Other Intangible Assets | 52.05 | 51.45 | 43.76 | 42.69 | 43.01 | 78.16 |
Long-Term Deferred Tax Assets | 595.45 | 605.58 | 623.1 | 677.16 | 588.05 | 631.87 |
Other Long-Term Assets | 807.68 | 788.45 | 780.13 | 814.28 | 1,062 | 170.82 |
Total Assets | 11,615 | 12,208 | 11,570 | 10,812 | 10,430 | 9,403 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 205.66 | 155.64 | 176.13 | 348.07 | 552.2 | 159.81 |
Accrued Expenses | 287.74 | 361.17 | 296.94 | 274.85 | 353.04 | 390.66 |
Short-Term Debt | 1,860 | 1,718 | 2,112 | 2,324 | 2,191 | 2,050 |
Current Portion of Long-Term Debt | 251.36 | 283.18 | 379.89 | 272.31 | 350.18 | 246.82 |
Current Portion of Leases | 31.71 | 26.09 | 38.79 | 41.95 | 44.06 | 25.78 |
Current Income Taxes Payable | 136.68 | 129.2 | 20.21 | 138.39 | 16.02 | 55.52 |
Other Current Liabilities | 149.81 | 241.02 | 283.6 | 312.65 | 286.42 | 303.12 |
Total Current Liabilities | 2,923 | 2,915 | 3,308 | 3,712 | 3,793 | 3,232 |
Long-Term Debt | 902.79 | 924.97 | 1,343 | 1,790 | 1,991 | 1,680 |
Long-Term Leases | 309.54 | 307.64 | 354.37 | 412.89 | 447.92 | 218.46 |
Pension & Post-Retirement Benefits | 44.83 | 45.46 | 47 | 58.69 | 59.82 | 66.99 |
Long-Term Deferred Tax Liabilities | 657.05 | 640.39 | 670.13 | 651.99 | 671.26 | 728.29 |
Other Long-Term Liabilities | 21.99 | 21.27 | 22.9 | 23.44 | 23.3 | 24.65 |
Total Liabilities | 4,859 | 4,854 | 5,746 | 6,649 | 6,987 | 5,950 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 867.47 | 867.47 | 867.47 | 867.47 | 867.47 | 867.47 |
Additional Paid-In Capital | 508.93 | 518.46 | 271.26 | 271.26 | 271.26 | 263.44 |
Retained Earnings | 3,742 | 3,666 | 2,046 | 1,752 | 1,738 | 2,118 |
Comprehensive Income & Other | 549.42 | 1,236 | 1,979 | 624.12 | 51.9 | -307.04 |
Total Common Equity | 5,668 | 6,287 | 5,164 | 3,514 | 2,929 | 2,942 |
Minority Interest | 1,088 | 1,066 | 660.39 | 648 | 514.77 | 511.39 |
Shareholders' Equity | 6,756 | 7,354 | 5,824 | 4,162 | 3,444 | 3,453 |
Total Liabilities & Equity | 11,615 | 12,208 | 11,570 | 10,812 | 10,430 | 9,403 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3,355 | 3,260 | 4,229 | 4,841 | 5,024 | 4,221 |
Net Cash (Debt) | -1,502 | -1,175 | -2,620 | -2,946 | -3,153 | -2,181 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -17.31 | -13.54 | -30.20 | -33.88 | -36.34 | -25.08 |
Filing Date Shares Outstanding | 86.75 | 86.75 | 86.75 | 86.75 | 86.75 | 86.75 |
Total Common Shares Outstanding | 86.75 | 86.75 | 86.75 | 86.75 | 86.75 | 86.75 |
Working Capital | 1,113 | 1,383 | 667.71 | 515.42 | 391.79 | 693.29 |
Book Value Per Share | 65.34 | 72.48 | 59.53 | 40.51 | 33.76 | 33.91 |
Tangible Book Value | 5,616 | 6,236 | 5,120 | 3,472 | 2,886 | 2,864 |
Tangible Book Value Per Share | 64.74 | 71.89 | 59.03 | 40.02 | 33.27 | 33.01 |
Land | 1,155 | 1,154 | 1,157 | 1,169 | 1,169 | 1,462 |
Buildings | 2,308 | 2,306 | 2,300 | 2,347 | 2,243 | 2,190 |
Machinery | 1,127 | 1,124 | 1,083 | 1,069 | 992.9 | 965.5 |
Construction In Progress | 184.77 | 159.43 | 27.78 | 3.55 | 36.12 | 48.41 |